Cadence Minerals Plc
("Cadence Minerals", "Cadence" or "the Company")
Exercise of Warrants
Cadence Minerals (AIM/NEX: KDNC; OTC: KDNCY) announce that, it has received warrant exercise notices to subscribe for 300,000 new ordinary shares in the Company at an exercise price of 8.5 pence per share (the "Warrant Shares") Subscription monies of £25,500 have been received by the Company in respect of the exercise of these warrants.
Application will be made for the Warrant Shares to be admitted to trading on AIM of London Stock Exchange plc and to and the AQSE Growth Market operated by Aquis Exchange Plc for the New Ordinary Shares ("Admission").
Admission is expected to occur on or around 30 April 2021. Upon Admission, the Company will have 148,649,098 Ordinary Shares in issue. There are no shares held in treasury. The total voting rights in the Company is therefore 148,649,098 and Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.
- Ends -
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
| For further information:
| |
| Cadence Minerals plc | +44 (0) 7879 584153 |
| Andrew Suckling | |
| Kiran Morzaria | |
| | |
| WH Ireland Limited (NOMAD & Broker) | +44 (0) 207 220 1666 |
| James Joyce | |
| James Sinclair-Ford | |
| | |
| Novum Securities Limited (Joint Broker) | +44 (0) 207 399 9400 |
| Jon Belliss | |
| | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
